Plain-language summary

This Phase 2 trial is studying Quality-of-Life Assessment, Questionnaire Administration, and other medications for people with cutaneous T-cell lymphoma (skin lymphoma). The study measures how well this treatment works and monitors for side effects. It is available at 1 US location.

Who can join (key eligibility)

• Age 18 Years or older
• See full trial listing for complete eligibility

Final eligibility is determined by the trial team. This list is a starting point only.

What's being tested

Quality-of-Life Assessment (OTHER): Ancillary studies | Questionnaire Administration (OTHER): Ancillary studies | Radiation Therapy (RADIATION): Undergo ultra low dose radiation therapy

Drugs / treatments

Quality-of-Life Assessment, Questionnaire Administration, Radiation Therapy

Treatment length

Ask the trial team for details

Visit frequency

Ask the trial team for details